HISTOLEVE (AFT Pharmaceuticals Pty Ltd)
Product name
HISTOLEVE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
139 (255 working days)
Active ingredients
fluticasone propionate
Registration type
New generic medicine
Indication
For the prophylaxis or treatment of allergic rhinitis for up to 6 months in adults 18 years and over.